系统性红斑狼疮患者的临床异质性、未满足的需求及长期预后
Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus Erythematosus.
作者信息
Sjöwall Christopher, Parodis Ioannis
机构信息
Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection/Rheumatology, Linköping University, SE-581 85 Linköping, Sweden.
Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet and Karolinska University Hospital, SE-171 76 Stockholm, Sweden.
出版信息
J Clin Med. 2022 Nov 21;11(22):6869. doi: 10.3390/jcm11226869.
Abstract
The clinical presentation of systemic lupus erythematosus (SLE) is highly heterogeneous, ranging from mild disease limited to skin and joint involvement to life-threatening conditions with renal impairment, severe cytopenias, central nervous system disease, and thromboembolic events [...].
摘要
系统性红斑狼疮（SLE）的临床表现高度异质性，从局限于皮肤和关节受累的轻症到伴有肾功能损害、严重血细胞减少、中枢神经系统疾病和血栓栓塞事件等危及生命的情况不等[……]
相似文献
1
Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus Erythematosus.
J Clin Med. 2022 Nov 21;11(22):6869. doi: 10.3390/jcm11226869.
2
An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management.
Cureus. 2022 Oct 15;14(10):e30330. doi: 10.7759/cureus.30330. eCollection 2022 Oct.
3
Systemic lupus erythematosus and ocular involvement: an overview.
Clin Exp Med. 2018 May;18(2):135-149. doi: 10.1007/s10238-017-0479-9. Epub 2017 Dec 14.
4
[Unmet needs in systemic lupus erythematosus].
Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(6):396-407. doi: 10.2177/jsci.40.396.
5
What's New in the Treatment of Systemic Lupus Erythematosus.
Front Med (Lausanne). 2021 Mar 5;8:655100. doi: 10.3389/fmed.2021.655100. eCollection 2021.
6
Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
Lupus. 2017 Feb;26(2):186-194. doi: 10.1177/0961203316660625. Epub 2016 Aug 19.
7
Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus.
Arthritis Care Res (Hoboken). 2012 Jun;64(6):833-7. doi: 10.1002/acr.21624. Epub 2012 Jan 30.
8
Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients.
Lupus. 1993 Oct;2(5):303-12. doi: 10.1177/096120339300200505.
9
Rowell Syndrome in Nigeria: Systemic Lupus Erythematosus Presenting as Recurrent Erythema Multiforme in a Young Woman.
Acta Dermatovenerol Croat. 2019 Sep;27(3):200-201.
10
Laboratory and Neuroimaging Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: Where Do We Stand, Where To Go?
Front Med (Lausanne). 2018 Dec 4;5:340. doi: 10.3389/fmed.2018.00340. eCollection 2018.
引用本文的文献
1
Belimumab efficacy in mucocutaneous manifestations of systemic lupus erythematosus: a large post hoc analysis of five phase III clinical trials.
Rheumatology (Oxford). 2025 Jul 1;64(7):4257-4266. doi: 10.1093/rheumatology/keaf145.
2
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study.
Rheumatology (Oxford). 2025 Apr 1;64(4):1904-1911. doi: 10.1093/rheumatology/keae376.
本文引用的文献
1
Fighting Fatigue in Systemic Lupus Erythematosus: Experience of Dehydroepiandrosterone on Clinical Parameters and Patient-Reported Outcomes.
J Clin Med. 2022 Sep 8;11(18):5300. doi: 10.3390/jcm11185300.
2
Good Long-Term Prognosis of Lupus Nephritis in the High-Income Afro-Caribbean Population of Martinique with Free Access to Healthcare.
J Clin Med. 2022 Aug 19;11(16):4860. doi: 10.3390/jcm11164860.
3
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Ann Rheum Dis. 2022 Nov;81(11):1541-1548. doi: 10.1136/ard-2022-222487. Epub 2022 Aug 9.
4
Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study.
J Clin Med. 2022 Jul 25;11(15):4316. doi: 10.3390/jcm11154316.
5
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort.
J Clin Med. 2022 Jun 22;11(13):3587. doi: 10.3390/jcm11133587.
6
Significance of Autoantibodies to Ki/SL as Biomarkers for Systemic Lupus Erythematosus and Sicca Syndrome.
J Clin Med. 2022 Jun 20;11(12):3529. doi: 10.3390/jcm11123529.
7
The Impacts of the Clinical and Genetic Factors on Chronic Damage in Caucasian Systemic Lupus Erythematosus Patients.
J Clin Med. 2022 Jun 12;11(12):3368. doi: 10.3390/jcm11123368.
8
Three Clinical Clusters Identified through Hierarchical Cluster Analysis Using Initial Laboratory Findings in Korean Patients with Systemic Lupus Erythematosus.
J Clin Med. 2022 Apr 25;11(9):2406. doi: 10.3390/jcm11092406.
9
How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study.
J Clin Med. 2022 Mar 27;11(7):1857. doi: 10.3390/jcm11071857.
10
Trends in Hospital Admissions and Death Causes in Patients with Systemic Lupus Erythematosus: Spanish National Registry.
J Clin Med. 2021 Dec 8;10(24):5749. doi: 10.3390/jcm10245749.
Zotero 插件